Adjunctive botulinum toxin type A: Fillers and light-based therapies

International Ophthalmology Clinics

Volumn 45, Issue 3, 2005, Pages 143-151

  Carruthers, Jean ^a   Carruthers, Alastair ^a  

^a Carruthers Cosmetic Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; COLLAGEN; COLLAGEN IMPLANT; FILLER; HYALURONIC ACID; MICROSPHERE; POLY(METHYL METHACRYLATE);

ABLATIVE SKIN RESURFACING; ADJUVANT THERAPY; CLINICAL TRIAL; ESTHETICS; HUMAN; IMPLANT; LASER RESURFACING; LASER SURGERY; NONABLATIVE SKIN RESURFACING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REJUVENATION; REVIEW; SKIN; SOFT TISSUE; SOFT TISSUE AUGMENTATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

BOTULINUM TOXIN TYPE A; COLLAGEN; COSMETIC TECHNIQUES; HUMANS; HYALURONIC ACID; LASER SURGERY; MICROSPHERES; NEUROMUSCULAR AGENTS; POLYMETHYL METHACRYLATE; PROSTHESES AND IMPLANTS; REJUVENATION; SKIN AGING;

EID: 22644436975     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000167162.33503.ad     Document Type: Review

References (23)

1. Clarke DP, Hanke CW, Swanson NA. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol. 1989;21:992-998.
2. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
3. Saylan Z. Facial fillers and their complications. Aesthetic Surg J. 2003;23:221-224.
4. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-933.
5. Honig JF, Brink U, Korabiowska M. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction. J Craniofac Surg. 2003;14:197-200.
6. Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg. 2003;29:971-973.
7. Lemperle G, Hazan-Gauthier N, Lemperle M. PMMA microspheres (Artecoll) for skin and soft tissue augmentation. Part II: clinical investigations. Plast Reconstr Surg. 1995;96: 627-634.
8. Pollack S. Some new injectable dermal filler materials: Hylaform, Restylane, and Artecoll. J Cutan Med Surg. 1999;3(Suppl 4):S27-S35.
9. Alcalay J, Alkalay R, Gat A, et al. Late-onset granulomatous reaction to Artecoll. Dermatol Surg. 2003;29:859-862.
10. Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthetic Plast Surg. 1998;22:356-365.
11. Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery: beyond the glabella. Clin Plast Surg. 2001;28:127-148.
12. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg. 2003;112:408-525.
13. Carruthers J, Carruthers A, Maberley D. Deep resting glabellar rhytides respond to BTX-A and Hylan B. Dermatol Surg. 2003;29:539-544.
14. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative BTX-A. Dermatol Surg. 2003; 29:802-809.
15. Patel MP, Talmor M, Nolan WB. Botox and collagen for glabellar furrows: advantages of combination therapy. Ann Plast Surg. 2004;52:442-447.
16. Alam M, Dover JS. Nonablative laser and light therapy: an approach to patient and device selection. Skin Ther Lett. 2003;8:4-7.
17. Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg. 2001;20:71-84.
18. Carruthers J, Carruthers A, Zelichowska A. The power of combined therapies: Botox and ablative facial laser resurfacing. Am J Cos Surg. 2000;17:129-131.
19. Vartanian AJ, Dayan SH. Facial rejuvenation using botulinum toxin A: review and updates. Facial Plast Surg. 2004;20:11-19.
20. 2 laser resurfacing. Dermatol Surg. 1999;25:259-261.
21. Zimbler MS, Holds JB, Kokoska MS, et al. Effect of botulinum toxin pretreatment on laser resurfacing, results: a prospective, randomized, blinded trial. Arch Facial Plast Surg. 2001;3:165-169.
22. Lowe N, Lask G, Yamauchi P, et al. Botulinum toxin type A (BTX-A) and ablative laser resurfacing (erbium: YAG): a comparison of efficacy and safety of combination therapy vs. ablative laser resurfacing alone for the treatment of crow's feet. Presented at the American Academy of Dermatology 2002 Summer Meeting; 2002 July 31-August 4, New York, NY.
23. Carruthers J, Carruthers A. The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type A chemodenervation. Dermatol Surg. 2004;30:355-366.